Ashrafi Mohammed, Bates Matt, Baguneid Mohamed, Alonso-Rasgado Teresa, Rautemaa-Richardson Riina, Bayat Ardeshir
Plastic and Reconstructive Surgery Research, Institute of Inflammation and Repair, Centre for Dermatological Research, University of Manchester, Manchester, United Kingdom.
University Hospital South Manchester NHS Foundation Trust, Wythenshawe Hospital, Manchester, United Kingdom.
Wound Repair Regen. 2017 Aug;25(4):574-590. doi: 10.1111/wrr.12563. Epub 2017 Aug 31.
Chronic cutaneous wound infections and surgical site infections (SSIs) present a huge burden on the healthcare system and can lead to increased morbidity and mortality. Current diagnostic methods of identifying and confirming infection involve culture-based and molecular methods. Both techniques are time-consuming and delays commonly lead to untargeted empirical treatment. An ideal diagnostic method would be noninvasive and highly sensitive and detect pathogenic organisms with a high degree of accuracy to allow targeted treatment. Volatile organic compounds (VOCs) are a diverse group of carbon-based molecules produced and released by humans and microorganisms. VOC detection has the potential in aiding cutaneous wound infection diagnostics using noninvasive and time-efficient methods. This review provides a comprehensive update on VOCs produced and emitted by bacteria commonly associated with chronic wounds and SSIs. VOC sampling has the advantage of being painless, time-efficient, noninvasive, and reproducible. VOCs emitted by these organisms are diverse. In vitro studies have identified potential signature volatile profiles, which can be used in detecting these microorganisms. Combining these profiles with volatile profiles emitted from acute, chronic and surgical wounds in vivo could potentially allow identification of bacterial-specific VOCs. VOC detection has the potential for a relatively inexpensive, portable, noninvasive, and reliable clinical diagnostic tool, which could be used in detecting cutaneous wound infections and guiding their optimal management.
慢性皮肤伤口感染和手术部位感染(SSIs)给医疗系统带来了巨大负担,并可能导致发病率和死亡率上升。目前识别和确认感染的诊断方法包括基于培养的方法和分子方法。这两种技术都很耗时,而延迟通常会导致无针对性的经验性治疗。理想的诊断方法应该是无创的、高度灵敏的,并且能够高度准确地检测出致病生物体,以便进行针对性治疗。挥发性有机化合物(VOCs)是由人类和微生物产生并释放的多种碳基分子。VOC检测有潜力通过无创且高效的方法辅助皮肤伤口感染的诊断。这篇综述全面更新了与慢性伤口和SSIs常见相关的细菌产生和排放的VOCs。VOC采样具有无痛、高效、无创和可重复的优点。这些生物体排放的VOCs多种多样。体外研究已经确定了潜在的标志性挥发性特征,可用于检测这些微生物。将这些特征与体内急性、慢性和手术伤口排放的挥发性特征相结合,有可能识别出细菌特异性VOCs。VOC检测有潜力成为一种相对廉价、便携、无创且可靠的临床诊断工具,可用于检测皮肤伤口感染并指导其最佳治疗。